These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 19846821)

  • 1. p16(INK4a) expression analysis as an ancillary tool for cytologic diagnosis of urothelial carcinoma.
    Nakazawa K; Murata S; Yuminamochi T; Ishii Y; Ohno S; Nakazawa T; Kondo T; Katoh R
    Am J Clin Pathol; 2009 Nov; 132(5):776-84. PubMed ID: 19846821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p16ink4 immunoreactivity is a reliable marker for urothelial carcinoma in situ.
    Yin M; Bastacky S; Parwani AV; McHale T; Dhir R
    Hum Pathol; 2008 Apr; 39(4):527-35. PubMed ID: 18234280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of p16(INK4a) in the diagnosis of low-grade urothelial carcinoma of the urinary bladder in urinary cytology.
    Alameda F; Juanpere N; Pijuan L; Lloveras B; Gimeno J; Baró T; Salido M; Serrano S; Lloreta J
    Cancer Cytopathol; 2012 Aug; 120(4):276-82. PubMed ID: 22419364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p16(INK4a) /Ki-67 dual labelling as a marker for the presence of high-grade cancer cells or disease progression in urinary cytopathology.
    Piaton E; Advenier AS; Carré C; Decaussin-Petrucci M; Mege-Lechevallier F; Ruffion A
    Cytopathology; 2013 Oct; 24(5):327-34. PubMed ID: 23003335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p16(INK4a) overexpression is not linked to oncogenic human papillomaviruses in patients with high-grade urothelial cancer cells.
    Piaton E; Casalegno JS; Advenier AS; Decaussin-Petrucci M; Mege-Lechevallier F; Ruffion A; Mekki Y
    Cancer Cytopathol; 2014 Oct; 122(10):760-9. PubMed ID: 25069600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p16INK4A in oral squamous cell carcinomas--a correlation with biological behaviors: immunohistochemical and FISH analysis.
    Suzuki H; Sugimura H; Hashimoto K
    J Oral Maxillofac Surg; 2006 Nov; 64(11):1617-23. PubMed ID: 17052587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of multicolour fluorescence in situ hybridisation (UroVysion) in the differential diagnosis of flat urothelial lesions.
    Schwarz S; Rechenmacher M; Filbeck T; Knuechel R; Blaszyk H; Hartmann A; Brockhoff G
    J Clin Pathol; 2008 Mar; 61(3):272-7. PubMed ID: 17693577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P16 immunoreactivity is an independent predictor of tumor progression in minimally invasive urothelial bladder carcinoma.
    Krüger S; Mahnken A; Kausch I; Feller AC
    Eur Urol; 2005 Apr; 47(4):463-7. PubMed ID: 15774242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Large-scale analysis of cell cycle regulators in urothelial bladder cancer identifies p16 and p27 as potentially useful prognostic markers.
    Brunner A; Verdorfer I; Prelog M; Mayerl C; Mikuz G; Tzankov A
    Pathobiology; 2008; 75(1):25-33. PubMed ID: 18334837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p16 INK4a overexpression and p16/Ki-67 dual labeling versus conventional urinary cytology in the evaluation of urothelial carcinoma.
    Piaton E; Carré C; Advenier AS; Decaussin-Petrucci M; Mège-Lechevallier F; Lantier P; Granier G; Ruffion A
    Cancer Cytopathol; 2014 Mar; 122(3):211-20. PubMed ID: 24302621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray.
    Higgins JP; Kaygusuz G; Wang L; Montgomery K; Mason V; Zhu SX; Marinelli RJ; Presti JC; van de Rijn M; Brooks JD
    Am J Surg Pathol; 2007 May; 31(5):673-80. PubMed ID: 17460449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is p16(INK4a) protein expression in oral ST lesions a reliable precancerous marker?
    Greer RO; Meyers A; Said SM; Shroyer KR
    Int J Oral Maxillofac Surg; 2008 Sep; 37(9):840-6. PubMed ID: 18606525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of cyclin D1 and E1 expression with disease progression and biomarkers in patients with nonmuscle-invasive urothelial cell carcinoma of the bladder.
    Shariat SF; Ashfaq R; Sagalowsky AI; Lotan Y
    Urol Oncol; 2007; 25(6):468-75. PubMed ID: 18047954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclooxygenase-2 expression on urothelial and inflammatory cells of cystoscopic biopsies and urine cytology as a possible predictive marker for bladder carcinoma.
    Moussa M; Omran Z; Nosseir M; Lotfy A; Swellam T
    APMIS; 2009 Jan; 117(1):45-52. PubMed ID: 19161536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invasive urothelial carcinoma with chordoid features: a report of 12 distinct cases characterized by prominent myxoid stroma and cordlike epithelial architecture.
    Cox RM; Schneider AG; Sangoi AR; Clingan WJ; Gokden N; McKenney JK
    Am J Surg Pathol; 2009 Aug; 33(8):1213-9. PubMed ID: 19542871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential Immunoreactivity of p16 in leiomyosarcomas and leiomyoma variants.
    Gannon BR; Manduch M; Childs TJ
    Int J Gynecol Pathol; 2008 Jan; 27(1):68-73. PubMed ID: 18156978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P16(INK4a) overexpression independent of Human Papilloma Virus (HPV) infection in rare subtypes of endometrial carcinomas.
    Giordano G; Azzoni C; D'Adda T; Merisio C
    Pathol Res Pract; 2007; 203(7):533-8. PubMed ID: 17498885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of level of expression of p16 (INK4a) in endocervical lesions of uterine cervix].
    Popovska S; Betova T; Tomov S; Gorchev G; Dikov T
    Akush Ginekol (Sofiia); 2005; 44(5):9-13. PubMed ID: 16313047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urothelial carcinoma with an inverted growth pattern can be distinguished from inverted papilloma by fluorescence in situ hybridization, immunohistochemistry, and morphologic analysis.
    Jones TD; Zhang S; Lopez-Beltran A; Eble JN; Sung MT; MacLennan GT; Montironi R; Tan PH; Zheng S; Baldridge LA; Cheng L
    Am J Surg Pathol; 2007 Dec; 31(12):1861-7. PubMed ID: 18043040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 9p21 index as estimated by dual-color fluorescence in situ hybridization is useful to predict urothelial carcinoma recurrence in bladder washing cytology.
    Kawauchi S; Sakai H; Ikemoto K; Eguchi S; Nakao M; Takihara H; Shimabukuro T; Furuya T; Oga A; Matsuyama H; Takahashi M; Sasaki K
    Hum Pathol; 2009 Dec; 40(12):1783-9. PubMed ID: 19733894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.